Kaposiform Hemangioendothelioma Presenting as Hydrops Fetalis | Zendy

SobrinoFernández Elena | Zendy; CamposDomínguez Minia | Zendy; GregorioHernández Rebeca | Zendy; HuertaAragonés Jorge | Zendy; BeléndezBieler Cristina | Zendy; LancharroZapata Ángel | Zendy; FrancoFernández María Luisa | Zendy; BernardoAtienza Belén | Zendy; SánchezLuna Manuel | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Premium

Kaposiform Hemangioendothelioma Presenting as Hydrops Fetalis

Author(s) -

SobrinoFernández Elena,

CamposDomínguez Minia,

GregorioHernández Rebeca,

HuertaAragonés Jorge,

BeléndezBieler Cristina,

LancharroZapata Ángel,

FrancoFernández María Luisa,

BernardoAtienza Belén,

SánchezLuna Manuel

Publication year - 2017

Publication title -

pediatric dermatology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.542

H-Index - 73

eISSN - 1525-1470

pISSN - 0736-8046

DOI - 10.1111/pde.13101

Subject(s) - medicine , hydrops fetalis , vincristine , prednisone , hemangioendothelioma , angiosarcoma , surgery , cyclophosphamide , pathology , fetus , chemotherapy , pregnancy , genetics , biology

We describe the case of a 33‐week preterm infant who developed nonimmune hydrops fetalis secondary to a kaposiform hemangioendothelioma ( KHE ). The tumor was successfully treated with vincristine, prednisone, ticlopidine, and aspirin. KHE can be an unusual cause of hydrops fetalis; in such cases, diagnosis can be challenging since generalized edema can obscure KHE .

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here

Accelerating Research